Figure 6-4-1 Approval of New Drugs
100
90
Developed overseas
Developed in Japan
Biotechnology-applied medicines
Number of new effective elements
80
70
60
50
40
30
20
10
0
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
Year
Note: The number of biotechnology-applied drugs is also included in the overall figure for new drugs.
Drugs "developed in Japan" are those originating in Japan using local materials.
Source: Ministry of Health and Welfare, Handbook of Application for New Drug Approval
See Table 6-4-1
Table of Contents
1995
Table 6-4-1 Approval of New Drugs (New Active Ingredients)
Number of newly approved drugs
Breakdown of newly approved drugs
BiotechnologyDeveloped in
Developed
Year
applied drugs
Japan
overseas
1980
33
18
15
1981
61
24
37
1982
36
17
20
1983
33
1
13
20
1984
26
9
18
1985
53
2
18
35
1986
33
1
16
17
1987
45
3
22
23
1988
45
3
18
28
1989
29
1
10
19
1990
33
2
12
23
1991
35
8
21
15
1992
31
2
18
13
1993
40
2
18
22
1994
45
3
23
22
1995
25
1
14
12
Notes: (1) The 1982, 1984,1988, 1990, 1991 and 1995 figures contain some ingredients
which were developed both in Japan and overseas (i.e. overlaps).
(2) Drugs "developed in Japan" mean those manufactured in Japan so that they
include those originally developed overseas. Drugs "developed overseas"
mean imported drugs.
Source: Ministry of Health and Welfare, Handbook of Application for New Drug Approval